77 related articles for article (PubMed ID: 16890411)
1. Cytochrome P450 (CYP) inhibition screening: comparison of three tests.
Turpeinen M; Korhonen LE; Tolonen A; Uusitalo J; Juvonen R; Raunio H; Pelkonen O
Eur J Pharm Sci; 2006 Oct; 29(2):130-8. PubMed ID: 16890411
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
4. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.
Obach RS; Walsky RL; Venkatakrishnan K; Gaman EA; Houston JB; Tremaine LM
J Pharmacol Exp Ther; 2006 Jan; 316(1):336-48. PubMed ID: 16192315
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
6. Highly miniaturized formats for in vitro drug metabolism assays using vivid fluorescent substrates and recombinant human cytochrome P450 enzymes.
Trubetskoy OV; Gibson JR; Marks BD
J Biomol Screen; 2005 Feb; 10(1):56-66. PubMed ID: 15695344
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates.
Cohen LH; Remley MJ; Raunig D; Vaz AD
Drug Metab Dispos; 2003 Aug; 31(8):1005-15. PubMed ID: 12867489
[TBL] [Abstract][Full Text] [Related]
8. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
Dasgupta M; Tang W; Caldwell GW; Yan Z
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
[TBL] [Abstract][Full Text] [Related]
9. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry.
Wu J; Hughes CS; Picard P; Letarte S; Gaudreault M; Lévesque JF; Nicoll-Griffith DA; Bateman KP
Anal Chem; 2007 Jun; 79(12):4657-65. PubMed ID: 17497828
[TBL] [Abstract][Full Text] [Related]
10. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s.
Bapiro TE; Egnell AC; Hasler JA; Masimirembwa CM
Drug Metab Dispos; 2001 Jan; 29(1):30-5. PubMed ID: 11124226
[TBL] [Abstract][Full Text] [Related]
11. Actions of ethnobotanically selected Cree anti-diabetic plants on human cytochrome P450 isoforms and flavin-containing monooxygenase 3.
Tam TW; Liu R; Arnason JT; Krantis A; Staines WA; Haddad PS; Foster BC
J Ethnopharmacol; 2009 Oct; 126(1):119-26. PubMed ID: 19665535
[TBL] [Abstract][Full Text] [Related]
12. Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator?
Linder CD; Renaud NA; Hutzler JM
Drug Metab Dispos; 2009 Jan; 37(1):10-3. PubMed ID: 18936109
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery.
Bell L; Bickford S; Nguyen PH; Wang J; He T; Zhang B; Friche Y; Zimmerlin A; Urban L; Bojanic D
J Biomol Screen; 2008 Jun; 13(5):343-53. PubMed ID: 18474896
[TBL] [Abstract][Full Text] [Related]
14. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen.
Wynalda MA; Wienkers LC
Drug Metab Dispos; 1997 Oct; 25(10):1211-4. PubMed ID: 9321526
[TBL] [Abstract][Full Text] [Related]
15. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
17. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H
Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186
[TBL] [Abstract][Full Text] [Related]
18. Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay.
Madgula VL; Ali Z; Smillie T; Khan IA; Walker LA; Khan SI
Planta Med; 2009 Mar; 75(4):329-32. PubMed ID: 19137500
[TBL] [Abstract][Full Text] [Related]
19. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
Perloff ES; Mason AK; Dehal SS; Blanchard AP; Morgan L; Ho T; Dandeneau A; Crocker RM; Chandler CM; Boily N; Crespi CL; Stresser DM
Xenobiotica; 2009 Feb; 39(2):99-112. PubMed ID: 19255936
[TBL] [Abstract][Full Text] [Related]
20. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism.
Ehnert S; Nussler AK; Lehmann A; Dooley S
Drug Metab Dispos; 2008 Sep; 36(9):1922-9. PubMed ID: 18559486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
